

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | porphyrin-containing compound biosynthetic process (GO:0006779) | 9.21059386 |
| 2 | heme biosynthetic process (GO:0006783) | 9.14303982 |
| 3 | tetrapyrrole biosynthetic process (GO:0033014) | 8.21199231 |
| 4 | response to methylmercury (GO:0051597) | 7.84927698 |
| 5 | porphyrin-containing compound metabolic process (GO:0006778) | 7.18493031 |
| 6 | heme metabolic process (GO:0042168) | 7.06743723 |
| 7 | response to lead ion (GO:0010288) | 6.30273787 |
| 8 | oxygen transport (GO:0015671) | 5.94324216 |
| 9 | erythrocyte maturation (GO:0043249) | 5.69728946 |
| 10 | hemoglobin metabolic process (GO:0020027) | 5.65491153 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.06208586 |
| 12 | tetrapyrrole metabolic process (GO:0033013) | 4.93914121 |
| 13 | lysine catabolic process (GO:0006554) | 4.75954532 |
| 14 | lysine metabolic process (GO:0006553) | 4.75954532 |
| 15 | erythrocyte development (GO:0048821) | 4.65405076 |
| 16 | response to insecticide (GO:0017085) | 4.64172225 |
| 17 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.54697054 |
| 18 | axon ensheathment in central nervous system (GO:0032291) | 4.47777057 |
| 19 | central nervous system myelination (GO:0022010) | 4.47777057 |
| 20 | intracellular estrogen receptor signaling pathway (GO:0030520) | 4.47386861 |
| 21 | regulation of response to osmotic stress (GO:0047484) | 4.46737760 |
| 22 | mannose metabolic process (GO:0006013) | 4.22957041 |
| 23 | aspartate family amino acid catabolic process (GO:0009068) | 4.20804699 |
| 24 | semaphorin-plexin signaling pathway (GO:0071526) | 4.15377714 |
| 25 | one-carbon compound transport (GO:0019755) | 4.06301809 |
| 26 | bicarbonate transport (GO:0015701) | 3.89882103 |
| 27 | protein retention in ER lumen (GO:0006621) | 3.86894848 |
| 28 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.82567806 |
| 29 | glycine transport (GO:0015816) | 3.75962935 |
| 30 | pigment biosynthetic process (GO:0046148) | 3.75192331 |
| 31 | heme transport (GO:0015886) | 3.73036006 |
| 32 | sodium ion export (GO:0071436) | 3.72676399 |
| 33 | negative regulation of cell size (GO:0045792) | 3.67037920 |
| 34 | drug transmembrane transport (GO:0006855) | 3.54260743 |
| 35 | response to mercury ion (GO:0046689) | 3.53504335 |
| 36 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.46466368 |
| 37 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.45308183 |
| 38 | cysteine metabolic process (GO:0006534) | 3.44935278 |
| 39 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.43514650 |
| 40 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.39512600 |
| 41 | glutathione biosynthetic process (GO:0006750) | 3.37045505 |
| 42 | GDP-mannose metabolic process (GO:0019673) | 3.36193416 |
| 43 | cell migration in hindbrain (GO:0021535) | 3.35563779 |
| 44 | myeloid cell development (GO:0061515) | 3.33288886 |
| 45 | phosphate ion transport (GO:0006817) | 3.32409276 |
| 46 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.32390137 |
| 47 | iron coordination entity transport (GO:1901678) | 3.30808604 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.30086122 |
| 49 | peptidyl-cysteine modification (GO:0018198) | 3.28773416 |
| 50 | synaptic vesicle maturation (GO:0016188) | 3.26196816 |
| 51 | proline biosynthetic process (GO:0006561) | 3.25419096 |
| 52 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.23444928 |
| 53 | gas transport (GO:0015669) | 3.21306675 |
| 54 | myelin maintenance (GO:0043217) | 3.20767105 |
| 55 | pigment metabolic process (GO:0042440) | 3.19171026 |
| 56 | motile cilium assembly (GO:0044458) | 3.19137859 |
| 57 | UV protection (GO:0009650) | 3.18801415 |
| 58 | actin filament capping (GO:0051693) | 3.18133095 |
| 59 | cell-cell junction maintenance (GO:0045217) | 3.17726528 |
| 60 | erythrocyte differentiation (GO:0030218) | 3.16911383 |
| 61 | fatty acid elongation (GO:0030497) | 3.15167678 |
| 62 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.13149470 |
| 63 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.11565764 |
| 64 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.08750502 |
| 65 | cell volume homeostasis (GO:0006884) | 3.08101756 |
| 66 | cofactor biosynthetic process (GO:0051188) | 3.07405742 |
| 67 | positive regulation of synapse maturation (GO:0090129) | 3.05138792 |
| 68 | creatine metabolic process (GO:0006600) | 3.04265464 |
| 69 | establishment of apical/basal cell polarity (GO:0035089) | 3.04246860 |
| 70 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.01183435 |
| 71 | short-chain fatty acid metabolic process (GO:0046459) | 2.98634270 |
| 72 | apoptotic process involved in morphogenesis (GO:0060561) | 2.97639396 |
| 73 | import into cell (GO:0098657) | 2.97210015 |
| 74 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.94303332 |
| 75 | histone H4 deacetylation (GO:0070933) | 2.92367822 |
| 76 | potassium ion import (GO:0010107) | 2.91821684 |
| 77 | modulation by virus of host process (GO:0019054) | 2.91625348 |
| 78 | axon ensheathment (GO:0008366) | 2.88479321 |
| 79 | ensheathment of neurons (GO:0007272) | 2.88479321 |
| 80 | positive regulation of histone deacetylation (GO:0031065) | 2.88340556 |
| 81 | endothelial cell chemotaxis (GO:0035767) | 2.87841128 |
| 82 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.86896590 |
| 83 | neutral amino acid transport (GO:0015804) | 2.85064874 |
| 84 | drug transport (GO:0015893) | 2.84757021 |
| 85 | myelination (GO:0042552) | 2.84507585 |
| 86 | tricarboxylic acid metabolic process (GO:0072350) | 2.84220629 |
| 87 | protein autoprocessing (GO:0016540) | 2.83105624 |
| 88 | regulation of chromatin binding (GO:0035561) | 2.80341321 |
| 89 | activation of Rac GTPase activity (GO:0032863) | 2.78605194 |
| 90 | phosphate ion transmembrane transport (GO:0035435) | 2.75091360 |
| 91 | iron ion import (GO:0097286) | 2.74694621 |
| 92 | response to arsenic-containing substance (GO:0046685) | 2.72690122 |
| 93 | thioester biosynthetic process (GO:0035384) | 2.71085737 |
| 94 | acyl-CoA biosynthetic process (GO:0071616) | 2.71085737 |
| 95 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.69142224 |
| 96 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.69124546 |
| 97 | glucose catabolic process (GO:0006007) | 2.67448110 |
| 98 | ear development (GO:0043583) | 2.67257249 |
| 99 | protein insertion into membrane (GO:0051205) | 2.67000122 |
| 100 | L-serine transport (GO:0015825) | 2.66867788 |
| 101 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.66787450 |
| 102 | antibacterial humoral response (GO:0019731) | 2.65941568 |
| 103 | cellular response to virus (GO:0098586) | 2.65375624 |
| 104 | activation of MAPKKK activity (GO:0000185) | 2.65217527 |
| 105 | histone H3 deacetylation (GO:0070932) | 2.64323996 |
| 106 | lung epithelium development (GO:0060428) | 2.63098334 |
| 107 | adherens junction assembly (GO:0034333) | 2.62575085 |
| 108 | negative regulation of actin filament depolymerization (GO:0030835) | 2.61712800 |
| 109 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.61593509 |
| 110 | atrioventricular valve morphogenesis (GO:0003181) | 2.61282277 |
| 111 | axonemal dynein complex assembly (GO:0070286) | 2.60891695 |
| 112 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.60658288 |
| 113 | modulation by virus of host morphology or physiology (GO:0019048) | 2.59848091 |
| 114 | NADH metabolic process (GO:0006734) | 2.59827069 |
| 115 | synaptic vesicle exocytosis (GO:0016079) | 2.59303303 |
| 116 | dicarboxylic acid catabolic process (GO:0043649) | 2.58770062 |
| 117 | locomotory exploration behavior (GO:0035641) | 2.58159483 |
| 118 | antimicrobial humoral response (GO:0019730) | 2.57775284 |
| 119 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.57599796 |
| 120 | osteoblast development (GO:0002076) | 2.57123542 |
| 121 | proline metabolic process (GO:0006560) | 2.55839551 |
| 122 | beta-amyloid metabolic process (GO:0050435) | 2.55630338 |
| 123 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.55139276 |
| 124 | establishment of monopolar cell polarity (GO:0061162) | 2.55139276 |
| 125 | protein targeting to plasma membrane (GO:0072661) | 2.53240623 |
| 126 | pentose-phosphate shunt (GO:0006098) | 2.53194699 |
| 127 | potassium ion homeostasis (GO:0055075) | 2.52984839 |
| 128 | L-phenylalanine catabolic process (GO:0006559) | 2.52627016 |
| 129 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.52627016 |
| 130 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.51995678 |
| 131 | modulation by symbiont of host cellular process (GO:0044068) | 2.50716098 |
| 132 | L-amino acid import (GO:0043092) | 2.49369138 |
| 133 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.48561135 |
| 134 | growth hormone secretion (GO:0030252) | 2.48333760 |
| 135 | maternal placenta development (GO:0001893) | 2.48085330 |
| 136 | glutamate metabolic process (GO:0006536) | 2.47668303 |
| 137 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.47331993 |
| 138 | retrograde transport, endosome to Golgi (GO:0042147) | 2.47180077 |
| 139 | urate metabolic process (GO:0046415) | 2.46888769 |
| 140 | regulation of ARF protein signal transduction (GO:0032012) | 2.46364037 |
| 141 | positive regulation of protein kinase C signaling (GO:0090037) | 2.46121466 |
| 142 | barbed-end actin filament capping (GO:0051016) | 2.46068004 |
| 143 | basement membrane organization (GO:0071711) | 2.44971426 |
| 144 | regulation of early endosome to late endosome transport (GO:2000641) | 2.44470702 |
| 145 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.43322502 |
| 146 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.41263558 |
| 147 | focal adhesion assembly (GO:0048041) | 2.40562754 |
| 148 | cell-substrate adherens junction assembly (GO:0007045) | 2.40562754 |
| 149 | regulation of cholesterol metabolic process (GO:0090181) | 2.40248215 |
| 150 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.38387240 |
| 151 | regulation of ARF GTPase activity (GO:0032312) | 2.37991170 |
| 152 | positive regulation of protein dephosphorylation (GO:0035307) | 2.36652848 |
| 153 | neuronal ion channel clustering (GO:0045161) | 2.36623473 |
| 154 | innate immune response in mucosa (GO:0002227) | 2.36493635 |
| 155 | dopamine receptor signaling pathway (GO:0007212) | 2.36442084 |
| 156 | peptide biosynthetic process (GO:0043043) | 2.35826042 |
| 157 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.35550367 |
| 158 | glucose 6-phosphate metabolic process (GO:0051156) | 2.35121622 |
| 159 | alpha-linolenic acid metabolic process (GO:0036109) | 2.35116307 |
| 160 | establishment of mitochondrion localization (GO:0051654) | 2.34606452 |
| 161 | snRNA metabolic process (GO:0016073) | 2.34582563 |
| 162 | metanephric tubule development (GO:0072170) | 2.33932344 |
| 163 | metanephric nephron tubule development (GO:0072234) | 2.33932344 |
| 164 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.33863407 |
| 165 | organic cation transport (GO:0015695) | 2.33193516 |
| 166 | quaternary ammonium group transport (GO:0015697) | 2.32933842 |
| 167 | L-amino acid transport (GO:0015807) | 2.31753503 |
| 168 | COPI coating of Golgi vesicle (GO:0048205) | 2.31129656 |
| 169 | Golgi transport vesicle coating (GO:0048200) | 2.31129656 |
| 170 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.30436471 |
| 171 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.29661460 |
| 172 | protein localization to endosome (GO:0036010) | 2.29594098 |
| 173 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.29213091 |
| 174 | protoporphyrinogen IX metabolic process (GO:0046501) | 13.5816194 |
| 175 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 12.4071371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 5.24485471 |
| 2 | GATA1_19941826_ChIP-Seq_K562_Human | 4.73561041 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.08609777 |
| 4 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 4.02400122 |
| 5 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.82453965 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.69649151 |
| 7 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 3.26521928 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.19348061 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.77296949 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.63690565 |
| 11 | GATA2_19941826_ChIP-Seq_K562_Human | 2.62390961 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.42240948 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.38953312 |
| 14 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.21934814 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.20462430 |
| 16 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.12784577 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.06301072 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.00385635 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.98665892 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95186111 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90441631 |
| 22 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.89613094 |
| 23 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.87207852 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86683656 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.77736633 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75701962 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.74817872 |
| 28 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.67875582 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.64789297 |
| 30 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.64035265 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.63361660 |
| 32 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.61155554 |
| 33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60855773 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56644581 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.55937932 |
| 36 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.51070469 |
| 37 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50804929 |
| 38 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.48809202 |
| 39 | * P68_20966046_ChIP-Seq_HELA_Human | 1.46987237 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.46349536 |
| 41 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45822119 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.45583313 |
| 43 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45225205 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44911698 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44391292 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.43640165 |
| 47 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42135017 |
| 48 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.40341190 |
| 49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38923045 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38712272 |
| 51 | MYC_22102868_ChIP-Seq_BL_Human | 1.38207121 |
| 52 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.38060210 |
| 53 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.37430819 |
| 54 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.36132300 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35616829 |
| 56 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34188056 |
| 57 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32738854 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32653932 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32277049 |
| 60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31899340 |
| 61 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.29266619 |
| 62 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26025003 |
| 63 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.25204852 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.24061715 |
| 65 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.22941236 |
| 66 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.22904574 |
| 67 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.22704239 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22470698 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21810209 |
| 70 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.21048113 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20332425 |
| 72 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.19931173 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19336765 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19284746 |
| 75 | SA1_27219007_Chip-Seq_Bcells_Human | 1.18644856 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18104599 |
| 77 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18036521 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16965059 |
| 79 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.15627914 |
| 80 | MAF_26560356_Chip-Seq_TH1_Human | 1.14909076 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12986735 |
| 82 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.12836822 |
| 83 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.12576442 |
| 84 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11152475 |
| 85 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.11061394 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10014051 |
| 87 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09920624 |
| 88 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09238126 |
| 89 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.09207390 |
| 90 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08958807 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08886081 |
| 92 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08552502 |
| 93 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08408820 |
| 94 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08385938 |
| 95 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08298475 |
| 96 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08020875 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07902832 |
| 98 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07743261 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07432256 |
| 100 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.07120422 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07001893 |
| 102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06036513 |
| 103 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05843262 |
| 104 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05644381 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05215905 |
| 106 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05052221 |
| 107 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.04732900 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04360220 |
| 109 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.03790827 |
| 110 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03714405 |
| 111 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03082085 |
| 112 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.02350637 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01044170 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00539765 |
| 115 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00458828 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00409890 |
| 117 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.99098029 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99018096 |
| 119 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98785180 |
| 120 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.98758177 |
| 121 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97979920 |
| 122 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95576341 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95100972 |
| 124 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.95009427 |
| 125 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.94769374 |
| 126 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94159176 |
| 127 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93557184 |
| 128 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92473371 |
| 129 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92400466 |
| 130 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90760502 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89596829 |
| 132 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.89409183 |
| 133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88314758 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86862424 |
| 135 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.86343767 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85868884 |
| 137 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.85410736 |
| 138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84754471 |
| 139 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.84745030 |
| 140 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84418335 |
| 141 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82259281 |
| 142 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80882992 |
| 143 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.79880172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 8.44211744 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 8.25454658 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.57905078 |
| 4 | MP0004043_abnormal_pH_regulation | 3.46552550 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.05736899 |
| 6 | MP0005083_abnormal_biliary_tract | 2.95481202 |
| 7 | MP0009278_abnormal_bone_marrow | 2.85964390 |
| 8 | MP0005076_abnormal_cell_differentiation | 2.70785246 |
| 9 | MP0002249_abnormal_larynx_morphology | 2.55106288 |
| 10 | MP0003329_amyloid_beta_deposits | 2.48369841 |
| 11 | MP0005636_abnormal_mineral_homeostasis | 2.46949079 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.38454738 |
| 13 | MP0000920_abnormal_myelination | 2.27093421 |
| 14 | MP0005360_urolithiasis | 2.18719157 |
| 15 | MP0000678_abnormal_parathyroid_gland | 2.07091816 |
| 16 | MP0001765_abnormal_ion_homeostasis | 1.98604287 |
| 17 | MP0003303_peritoneal_inflammation | 1.97191923 |
| 18 | MP0005377_hearing/vestibular/ear_phenot | 1.90596510 |
| 19 | MP0003878_abnormal_ear_physiology | 1.90596510 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 1.79848363 |
| 21 | MP0005409_darkened_coat_color | 1.78046643 |
| 22 | MP0004270_analgesia | 1.72551062 |
| 23 | MP0000003_abnormal_adipose_tissue | 1.68226062 |
| 24 | MP0001529_abnormal_vocalization | 1.67414404 |
| 25 | MP0005332_abnormal_amino_acid | 1.67038358 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 1.65802767 |
| 27 | MP0002822_catalepsy | 1.62714743 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.62211785 |
| 29 | MP0000681_abnormal_thyroid_gland | 1.61441763 |
| 30 | MP0004885_abnormal_endolymph | 1.60949580 |
| 31 | MP0002064_seizures | 1.60797100 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.58806710 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.58040579 |
| 34 | MP0003279_aneurysm | 1.52195485 |
| 35 | MP0008961_abnormal_basal_metabolism | 1.51861817 |
| 36 | MP0003690_abnormal_glial_cell | 1.50685140 |
| 37 | MP0001348_abnormal_lacrimal_gland | 1.50521011 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.50195136 |
| 39 | MP0005171_absent_coat_pigmentation | 1.49888731 |
| 40 | MP0000566_synostosis | 1.47975433 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.47290123 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.47290123 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.44692719 |
| 44 | MP0000751_myopathy | 1.44491296 |
| 45 | MP0002272_abnormal_nervous_system | 1.44062661 |
| 46 | MP0003195_calcinosis | 1.43381847 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.41554786 |
| 48 | MP0000747_muscle_weakness | 1.38497891 |
| 49 | MP0000537_abnormal_urethra_morphology | 1.37092103 |
| 50 | MP0005451_abnormal_body_composition | 1.32129733 |
| 51 | MP0000604_amyloidosis | 1.30216551 |
| 52 | MP0002735_abnormal_chemical_nociception | 1.28906738 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.26594212 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.25614655 |
| 55 | MP0008569_lethality_at_weaning | 1.25272997 |
| 56 | MP0010030_abnormal_orbit_morphology | 1.24487805 |
| 57 | MP0004381_abnormal_hair_follicle | 1.23785562 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.21638883 |
| 59 | MP0001756_abnormal_urination | 1.21636941 |
| 60 | MP0004142_abnormal_muscle_tone | 1.20357013 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.19709089 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.19579142 |
| 63 | MP0009046_muscle_twitch | 1.19352765 |
| 64 | MP0001502_abnormal_circadian_rhythm | 1.18099902 |
| 65 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17745671 |
| 66 | MP0005670_abnormal_white_adipose | 1.16930434 |
| 67 | MP0008260_abnormal_autophagy | 1.16908418 |
| 68 | MP0001188_hyperpigmentation | 1.16868748 |
| 69 | MP0002229_neurodegeneration | 1.16390165 |
| 70 | MP0001958_emphysema | 1.15035323 |
| 71 | MP0008775_abnormal_heart_ventricle | 1.15013453 |
| 72 | MP0002736_abnormal_nociception_after | 1.14502855 |
| 73 | MP0009745_abnormal_behavioral_response | 1.13645002 |
| 74 | MP0002734_abnormal_mechanical_nocicepti | 1.13635059 |
| 75 | MP0009384_cardiac_valve_regurgitation | 1.11266995 |
| 76 | MP0003879_abnormal_hair_cell | 1.09886955 |
| 77 | MP0009780_abnormal_chondrocyte_physiolo | 1.09662006 |
| 78 | MP0008872_abnormal_physiological_respon | 1.09223802 |
| 79 | MP0005058_abnormal_lysosome_morphology | 1.09147811 |
| 80 | MP0009840_abnormal_foam_cell | 1.06936663 |
| 81 | MP0005535_abnormal_body_temperature | 1.06925351 |
| 82 | MP0009931_abnormal_skin_appearance | 1.05216909 |
| 83 | MP0003634_abnormal_glial_cell | 1.04784369 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.04217316 |
| 85 | MP0001968_abnormal_touch/_nociception | 1.03046230 |
| 86 | MP0000749_muscle_degeneration | 1.02995952 |
| 87 | MP0003632_abnormal_nervous_system | 1.02868338 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 1.01880182 |
| 89 | MP0003631_nervous_system_phenotype | 1.01770568 |
| 90 | MP0003633_abnormal_nervous_system | 1.00606970 |
| 91 | MP0002118_abnormal_lipid_homeostasis | 0.99727059 |
| 92 | MP0002063_abnormal_learning/memory/cond | 0.93660820 |
| 93 | MP0006054_spinal_hemorrhage | 0.93069342 |
| 94 | MP0002733_abnormal_thermal_nociception | 0.92472214 |
| 95 | MP0000467_abnormal_esophagus_morphology | 0.91673372 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.91463349 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.89802081 |
| 98 | MP0001270_distended_abdomen | 0.88110162 |
| 99 | MP0003880_abnormal_central_pattern | 0.86974605 |
| 100 | MP0002098_abnormal_vibrissa_morphology | 0.86115304 |
| 101 | MP0004233_abnormal_muscle_weight | 0.85331516 |
| 102 | MP0002067_abnormal_sensory_capabilities | 0.85309174 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 0.85247791 |
| 104 | MP0005508_abnormal_skeleton_morphology | 0.83296821 |
| 105 | MP0001970_abnormal_pain_threshold | 0.83181755 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.81705175 |
| 107 | MP0003075_altered_response_to | 0.81191628 |
| 108 | MP0001486_abnormal_startle_reflex | 0.81187325 |
| 109 | MP0001664_abnormal_digestion | 0.81165566 |
| 110 | MP0000858_altered_metastatic_potential | 0.80961580 |
| 111 | MP0004811_abnormal_neuron_physiology | 0.80166407 |
| 112 | MP0003186_abnormal_redox_activity | 0.80096522 |
| 113 | MP0005503_abnormal_tendon_morphology | 0.79244740 |
| 114 | MP0003436_decreased_susceptibility_to | 0.78888338 |
| 115 | MP0001666_abnormal_nutrient_absorption | 0.77441281 |
| 116 | MP0003111_abnormal_nucleus_morphology | 0.76418415 |
| 117 | MP0005386_behavior/neurological_phenoty | 0.76418222 |
| 118 | MP0004924_abnormal_behavior | 0.76418222 |
| 119 | MP0001849_ear_inflammation | 0.75631163 |
| 120 | MP0003283_abnormal_digestive_organ | 0.74461894 |
| 121 | MP0004858_abnormal_nervous_system | 0.73719007 |
| 122 | MP0004130_abnormal_muscle_cell | 0.73154080 |
| 123 | MP0004133_heterotaxia | 0.73038209 |
| 124 | MP0002932_abnormal_joint_morphology | 0.72009183 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.71721030 |
| 126 | MP0002060_abnormal_skin_morphology | 0.71225441 |
| 127 | MP0002089_abnormal_postnatal_growth/wei | 0.70358868 |
| 128 | MP0002269_muscular_atrophy | 0.70093049 |
| 129 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70048756 |
| 130 | MP0003123_paternal_imprinting | 0.69648088 |
| 131 | MP0008874_decreased_physiological_sensi | 0.69623197 |
| 132 | MP0003942_abnormal_urinary_system | 0.69284508 |
| 133 | MP0005423_abnormal_somatic_nervous | 0.69246666 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.69168179 |
| 135 | MP0004085_abnormal_heartbeat | 0.69074803 |
| 136 | MP0002877_abnormal_melanocyte_morpholog | 0.68302203 |
| 137 | MP0005621_abnormal_cell_physiology | 0.68296705 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.67916144 |
| 139 | MP0000955_abnormal_spinal_cord | 0.67491704 |
| 140 | MP0002572_abnormal_emotion/affect_behav | 0.66631427 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.66161011 |
| 142 | MP0003252_abnormal_bile_duct | 0.65817783 |
| 143 | MP0000609_abnormal_liver_physiology | 0.63631564 |
| 144 | MP0009333_abnormal_splenocyte_physiolog | 0.63225130 |
| 145 | MP0002796_impaired_skin_barrier | 0.63077637 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.62883957 |
| 147 | MP0003045_fibrosis | 0.62661414 |
| 148 | MP0004947_skin_inflammation | 0.62421725 |
| 149 | MP0000767_abnormal_smooth_muscle | 0.62393130 |
| 150 | MP0010234_abnormal_vibrissa_follicle | 0.61745166 |
| 151 | MP0003091_abnormal_cell_migration | 0.61636145 |
| 152 | MP0002933_joint_inflammation | 0.60985372 |
| 153 | MP0005394_taste/olfaction_phenotype | 0.60511048 |
| 154 | MP0005499_abnormal_olfactory_system | 0.60511048 |
| 155 | MP0002078_abnormal_glucose_homeostasis | 0.60210006 |
| 156 | MP0010771_integument_phenotype | 0.59857435 |
| 157 | MP0010329_abnormal_lipoprotein_level | 0.59507061 |
| 158 | MP0002970_abnormal_white_adipose | 0.59121769 |
| 159 | MP0003948_abnormal_gas_homeostasis | 0.58711336 |
| 160 | MP0000733_abnormal_muscle_development | 0.58242915 |
| 161 | MP0005501_abnormal_skin_physiology | 0.58150180 |
| 162 | MP0005452_abnormal_adipose_tissue | 0.57745491 |
| 163 | MP0001440_abnormal_grooming_behavior | 0.56700163 |
| 164 | MP0002116_abnormal_craniofacial_bone | 0.55631631 |
| 165 | MP0002138_abnormal_hepatobiliary_system | 0.55443613 |
| 166 | MP0004185_abnormal_adipocyte_glucose | 0.54663805 |
| 167 | MP0002972_abnormal_cardiac_muscle | 0.54612673 |
| 168 | MP0002882_abnormal_neuron_morphology | 0.54234038 |
| 169 | MP0000534_abnormal_ureter_morphology | 0.52495163 |
| 170 | MP0000026_abnormal_inner_ear | 0.51170712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 9.91909422 |
| 2 | Poikilocytosis (HP:0004447) | 8.07704098 |
| 3 | Acanthocytosis (HP:0001927) | 5.64423243 |
| 4 | Reticulocytosis (HP:0001923) | 5.52025529 |
| 5 | Diaphragmatic weakness (HP:0009113) | 5.02789801 |
| 6 | Cholelithiasis (HP:0001081) | 4.79068934 |
| 7 | Insomnia (HP:0100785) | 4.74304050 |
| 8 | Abnormal gallbladder morphology (HP:0012437) | 4.45585339 |
| 9 | Increased circulating renin level (HP:0000848) | 4.23221838 |
| 10 | Hypochromic microcytic anemia (HP:0004840) | 4.19958656 |
| 11 | Paralysis (HP:0003470) | 4.07898691 |
| 12 | Hyperbilirubinemia (HP:0002904) | 3.97611157 |
| 13 | Obstructive sleep apnea (HP:0002870) | 3.71620606 |
| 14 | Ileus (HP:0002595) | 3.58996204 |
| 15 | Hypokalemic alkalosis (HP:0001949) | 3.45124914 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 3.31732482 |
| 17 | Cholecystitis (HP:0001082) | 3.31732482 |
| 18 | Metabolic alkalosis (HP:0200114) | 3.30384857 |
| 19 | Upper limb amyotrophy (HP:0009129) | 3.28461851 |
| 20 | Distal upper limb amyotrophy (HP:0007149) | 3.28461851 |
| 21 | Abnormality of the gallbladder (HP:0005264) | 3.24157127 |
| 22 | Hyperacusis (HP:0010780) | 3.23899343 |
| 23 | Abnormality of reticulocytes (HP:0004312) | 3.17440935 |
| 24 | Broad distal phalanx of finger (HP:0009836) | 3.16886479 |
| 25 | J-shaped sella turcica (HP:0002680) | 3.12277469 |
| 26 | Cerebral aneurysm (HP:0004944) | 3.10635044 |
| 27 | Ulnar bowing (HP:0003031) | 3.10402502 |
| 28 | Gout (HP:0001997) | 3.07060316 |
| 29 | Broad face (HP:0000283) | 3.05093935 |
| 30 | Hypomagnesemia (HP:0002917) | 3.03988287 |
| 31 | Abnormality of sodium homeostasis (HP:0010931) | 3.02104563 |
| 32 | Osteomalacia (HP:0002749) | 2.98366137 |
| 33 | Nasal polyposis (HP:0100582) | 2.97567655 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.96888597 |
| 35 | Confusion (HP:0001289) | 2.95200049 |
| 36 | Atelectasis (HP:0100750) | 2.95195878 |
| 37 | Hyperactive renin-angiotensin system (HP:0000841) | 2.93214624 |
| 38 | Neurofibrillary tangles (HP:0002185) | 2.92573048 |
| 39 | Stridor (HP:0010307) | 2.92381802 |
| 40 | Hyponatremia (HP:0002902) | 2.91391690 |
| 41 | Cervical subluxation (HP:0003308) | 2.88914863 |
| 42 | Thin bony cortex (HP:0002753) | 2.87482823 |
| 43 | Abnormality of magnesium homeostasis (HP:0004921) | 2.82908404 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.82404827 |
| 45 | Global brain atrophy (HP:0002283) | 2.80069569 |
| 46 | Abnormal hemoglobin (HP:0011902) | 2.74357560 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.71362537 |
| 48 | Hand muscle atrophy (HP:0009130) | 2.70833750 |
| 49 | Supranuclear gaze palsy (HP:0000605) | 2.67069045 |
| 50 | Hyperaldosteronism (HP:0000859) | 2.54802691 |
| 51 | Myokymia (HP:0002411) | 2.52889260 |
| 52 | Hypochromic anemia (HP:0001931) | 2.51244282 |
| 53 | Depression (HP:0000716) | 2.50503617 |
| 54 | Polyuria (HP:0000103) | 2.49745918 |
| 55 | Polycythemia (HP:0001901) | 2.49219751 |
| 56 | Lymphangioma (HP:0100764) | 2.48743329 |
| 57 | Abnormality of renin-angiotensin system (HP:0000847) | 2.45697577 |
| 58 | Abnormality of chloride homeostasis (HP:0011422) | 2.44540247 |
| 59 | Turricephaly (HP:0000262) | 2.43030131 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42394720 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42394720 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42394720 |
| 63 | Annular pancreas (HP:0001734) | 2.41342535 |
| 64 | Renal salt wasting (HP:0000127) | 2.40971434 |
| 65 | Hemorrhage of the eye (HP:0011885) | 2.39179942 |
| 66 | Ketoacidosis (HP:0001993) | 2.38332598 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.36571878 |
| 68 | Abnormal urine output (HP:0012590) | 2.36217342 |
| 69 | Anxiety (HP:0000739) | 2.34626487 |
| 70 | Abnormality of the fingertips (HP:0001211) | 2.33618555 |
| 71 | Delusions (HP:0000746) | 2.32944935 |
| 72 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.30725147 |
| 73 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.30725147 |
| 74 | Intention tremor (HP:0002080) | 2.29373251 |
| 75 | Increased serum ferritin (HP:0003281) | 2.29128780 |
| 76 | Long palpebral fissure (HP:0000637) | 2.26290657 |
| 77 | Nonimmune hydrops fetalis (HP:0001790) | 2.26052162 |
| 78 | Onion bulb formation (HP:0003383) | 2.25273177 |
| 79 | Dysostosis multiplex (HP:0000943) | 2.23498532 |
| 80 | Protrusio acetabuli (HP:0003179) | 2.22260583 |
| 81 | Metaphyseal cupping (HP:0003021) | 2.21056403 |
| 82 | Short nail (HP:0001799) | 2.19946853 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19295126 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.19295126 |
| 85 | Nuclear cataract (HP:0100018) | 2.19064585 |
| 86 | Polydipsia (HP:0001959) | 2.18791457 |
| 87 | Abnormal drinking behavior (HP:0030082) | 2.18791457 |
| 88 | Vertebral compression fractures (HP:0002953) | 2.17273904 |
| 89 | Postural instability (HP:0002172) | 2.16265197 |
| 90 | Spastic gait (HP:0002064) | 2.15767936 |
| 91 | Papilledema (HP:0001085) | 2.15582751 |
| 92 | Ankle clonus (HP:0011448) | 2.14580629 |
| 93 | Shallow orbits (HP:0000586) | 2.13676962 |
| 94 | Cutaneous photosensitivity (HP:0000992) | 2.12603444 |
| 95 | Increased cerebral lipofuscin (HP:0011813) | 2.12510245 |
| 96 | Abnormal auditory evoked potentials (HP:0006958) | 2.12363119 |
| 97 | Abnormality of renal excretion (HP:0011036) | 2.11584794 |
| 98 | Rickets (HP:0002748) | 2.11378762 |
| 99 | Joint stiffness (HP:0001387) | 2.10756582 |
| 100 | Distal lower limb muscle weakness (HP:0009053) | 2.10587474 |
| 101 | Psychosis (HP:0000709) | 2.10311711 |
| 102 | Abnormality of the thoracic spine (HP:0100711) | 2.10064558 |
| 103 | Ketosis (HP:0001946) | 2.08240852 |
| 104 | Visual hallucinations (HP:0002367) | 2.07542351 |
| 105 | Myopathic facies (HP:0002058) | 2.07299801 |
| 106 | Flattened epiphyses (HP:0003071) | 2.06844730 |
| 107 | Spastic tetraparesis (HP:0001285) | 2.05646129 |
| 108 | Microcytic anemia (HP:0001935) | 2.04618289 |
| 109 | Urinary urgency (HP:0000012) | 2.03519717 |
| 110 | Easy fatigability (HP:0003388) | 2.03082108 |
| 111 | Renal tubular acidosis (HP:0001947) | 2.02790834 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99404287 |
| 113 | Testicular atrophy (HP:0000029) | 1.99346101 |
| 114 | Metabolic acidosis (HP:0001942) | 1.98882677 |
| 115 | Truncal ataxia (HP:0002078) | 1.97769749 |
| 116 | Premature rupture of membranes (HP:0001788) | 1.97132240 |
| 117 | Increased connective tissue (HP:0009025) | 1.96365613 |
| 118 | Abnormality of the aortic arch (HP:0012303) | 1.96224453 |
| 119 | Hepatocellular carcinoma (HP:0001402) | 1.95841275 |
| 120 | Insidious onset (HP:0003587) | 1.94615632 |
| 121 | Termporal pattern (HP:0011008) | 1.94615632 |
| 122 | Hypoglycemic coma (HP:0001325) | 1.93590516 |
| 123 | Abnormality of the corticospinal tract (HP:0002492) | 1.93366663 |
| 124 | Rectal prolapse (HP:0002035) | 1.92281527 |
| 125 | Proximal tubulopathy (HP:0000114) | 1.90812889 |
| 126 | Dysmetria (HP:0001310) | 1.90026906 |
| 127 | Pheochromocytoma (HP:0002666) | 1.89848251 |
| 128 | Scanning speech (HP:0002168) | 1.88392626 |
| 129 | Difficulty climbing stairs (HP:0003551) | 1.88080332 |
| 130 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.87759102 |
| 131 | Precocious puberty (HP:0000826) | 1.87433072 |
| 132 | Alkalosis (HP:0001948) | 1.86661285 |
| 133 | Hyperthyroidism (HP:0000836) | 1.85872210 |
| 134 | Thoracic kyphosis (HP:0002942) | 1.85823509 |
| 135 | Achilles tendon contracture (HP:0001771) | 1.85767411 |
| 136 | Hypertensive crisis (HP:0100735) | 1.85712187 |
| 137 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.83345715 |
| 138 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.83157651 |
| 139 | Biconcave vertebral bodies (HP:0004586) | 1.82351740 |
| 140 | Cerebral hypomyelination (HP:0006808) | 1.81398342 |
| 141 | Mitral regurgitation (HP:0001653) | 1.81087886 |
| 142 | Cerebral palsy (HP:0100021) | 1.79108676 |
| 143 | Hypertriglyceridemia (HP:0002155) | 1.78926781 |
| 144 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.78678812 |
| 145 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.78678812 |
| 146 | Nephrocalcinosis (HP:0000121) | 1.78664421 |
| 147 | Generalized aminoaciduria (HP:0002909) | 1.78418406 |
| 148 | Tetany (HP:0001281) | 1.76706775 |
| 149 | Abnormality of iron homeostasis (HP:0011031) | 1.76096119 |
| 150 | Abnormal social behavior (HP:0012433) | 1.76039587 |
| 151 | Impaired social interactions (HP:0000735) | 1.76039587 |
| 152 | Germ cell neoplasia (HP:0100728) | 1.75425345 |
| 153 | Spastic paraparesis (HP:0002313) | 1.75064815 |
| 154 | Neuronal loss in central nervous system (HP:0002529) | 1.74497705 |
| 155 | Bronchomalacia (HP:0002780) | 1.74202989 |
| 156 | Bowed forearm bones (HP:0003956) | 1.74083971 |
| 157 | Bowing of the arm (HP:0006488) | 1.74083971 |
| 158 | Truncus arteriosus (HP:0001660) | 1.73836332 |
| 159 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.73801182 |
| 160 | Disproportionate tall stature (HP:0001519) | 1.73658022 |
| 161 | Hypercortisolism (HP:0001578) | 1.72368198 |
| 162 | Fragile skin (HP:0001030) | 1.71975199 |
| 163 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.71940547 |
| 164 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71898932 |
| 165 | Long toe (HP:0010511) | 1.71624835 |
| 166 | Hyperparathyroidism (HP:0000843) | 1.71447844 |
| 167 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71287256 |
| 168 | Cerebral hemorrhage (HP:0001342) | 1.71201279 |
| 169 | Pointed chin (HP:0000307) | 1.70859128 |
| 170 | Abnormality of purine metabolism (HP:0004352) | 1.69027479 |
| 171 | Vomiting (HP:0002013) | 1.68687098 |
| 172 | Increased purine levels (HP:0004368) | 1.68159855 |
| 173 | Hyperuricemia (HP:0002149) | 1.68159855 |
| 174 | Progressive microcephaly (HP:0000253) | 1.67051354 |
| 175 | Hypercalciuria (HP:0002150) | 1.66600280 |
| 176 | Clonus (HP:0002169) | 1.65614583 |
| 177 | Neuroendocrine neoplasm (HP:0100634) | 1.65168005 |
| 178 | Delayed CNS myelination (HP:0002188) | 1.63851350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 3.89532972 |
| 2 | SIK1 | 3.64622577 |
| 3 | EIF2AK1 | 3.64440628 |
| 4 | OXSR1 | 3.37432816 |
| 5 | STK39 | 2.83161774 |
| 6 | PRPF4B | 2.70487827 |
| 7 | SMG1 | 2.61772185 |
| 8 | BCKDK | 2.58919644 |
| 9 | EPHA2 | 2.42237759 |
| 10 | MAPK15 | 2.39572383 |
| 11 | PRKD3 | 2.37468691 |
| 12 | TRIB3 | 2.15929883 |
| 13 | WNK3 | 2.07112630 |
| 14 | EPHB1 | 1.95741592 |
| 15 | NTRK1 | 1.90912789 |
| 16 | BRSK1 | 1.84126645 |
| 17 | KSR2 | 1.83789135 |
| 18 | MAPKAPK5 | 1.79945167 |
| 19 | SCYL2 | 1.74101199 |
| 20 | MAP2K3 | 1.72702835 |
| 21 | SGK494 | 1.67658700 |
| 22 | SGK223 | 1.67658700 |
| 23 | WNK1 | 1.64774314 |
| 24 | DAPK2 | 1.60178641 |
| 25 | IRAK3 | 1.59425740 |
| 26 | EEF2K | 1.56807022 |
| 27 | RPS6KA2 | 1.56796097 |
| 28 | STK4 | 1.54584065 |
| 29 | TAOK1 | 1.52617660 |
| 30 | TESK1 | 1.51368939 |
| 31 | SIK2 | 1.46769526 |
| 32 | PRKD2 | 1.41597421 |
| 33 | TAOK2 | 1.38586522 |
| 34 | PRKCH | 1.37148152 |
| 35 | MAP3K9 | 1.34619774 |
| 36 | MST1R | 1.30254030 |
| 37 | TNK2 | 1.24807307 |
| 38 | TLK1 | 1.24023768 |
| 39 | CAMK1G | 1.22366117 |
| 40 | NME2 | 1.20692572 |
| 41 | TESK2 | 1.20594457 |
| 42 | CDK19 | 1.16918544 |
| 43 | PAK6 | 1.16537685 |
| 44 | UHMK1 | 1.14416011 |
| 45 | MAP3K6 | 1.14082025 |
| 46 | RPS6KL1 | 1.13868850 |
| 47 | RPS6KC1 | 1.13868850 |
| 48 | MET | 1.12506663 |
| 49 | MAP3K3 | 1.11584388 |
| 50 | PTK6 | 1.09147696 |
| 51 | NTRK3 | 1.07353951 |
| 52 | EPHA4 | 1.06192042 |
| 53 | NEK1 | 1.06148710 |
| 54 | MAP3K8 | 1.06083783 |
| 55 | ZAK | 1.05816745 |
| 56 | CDK15 | 1.05024682 |
| 57 | TTN | 1.02330996 |
| 58 | MINK1 | 1.01348925 |
| 59 | BRAF | 1.01017862 |
| 60 | MAP2K2 | 1.00691006 |
| 61 | CDK14 | 1.00345667 |
| 62 | CDK5 | 0.99695313 |
| 63 | MAP3K11 | 0.99562210 |
| 64 | STK10 | 0.97173905 |
| 65 | MTOR | 0.96452883 |
| 66 | RPS6KA6 | 0.95480085 |
| 67 | CDK18 | 0.94504600 |
| 68 | CDK11A | 0.93934721 |
| 69 | PAK4 | 0.91779720 |
| 70 | PKN2 | 0.89914348 |
| 71 | PRKAA1 | 0.87733442 |
| 72 | HIPK2 | 0.86198908 |
| 73 | ICK | 0.85242195 |
| 74 | RET | 0.83260918 |
| 75 | MAPK11 | 0.81686229 |
| 76 | PDPK1 | 0.81210120 |
| 77 | RIPK1 | 0.81136217 |
| 78 | PTK2B | 0.79711469 |
| 79 | ERN1 | 0.78858343 |
| 80 | MAP3K2 | 0.78297011 |
| 81 | MAPKAPK3 | 0.76747917 |
| 82 | SGK3 | 0.76261440 |
| 83 | KDR | 0.75868988 |
| 84 | TBK1 | 0.75811389 |
| 85 | MAP3K7 | 0.73776661 |
| 86 | JAK2 | 0.73684078 |
| 87 | CDC7 | 0.72052747 |
| 88 | MAP3K1 | 0.71497362 |
| 89 | LRRK2 | 0.68861364 |
| 90 | CAMKK1 | 0.67136175 |
| 91 | TTK | 0.67095588 |
| 92 | MAP2K6 | 0.66454367 |
| 93 | SGK1 | 0.66175636 |
| 94 | PIM2 | 0.65814001 |
| 95 | BRD4 | 0.65396669 |
| 96 | ROCK2 | 0.65011231 |
| 97 | PAK3 | 0.64554942 |
| 98 | FGFR4 | 0.64184625 |
| 99 | SIK3 | 0.63714222 |
| 100 | ZAP70 | 0.62377802 |
| 101 | PKN1 | 0.60739382 |
| 102 | GRK6 | 0.60534948 |
| 103 | MAP2K1 | 0.60405686 |
| 104 | AURKA | 0.59630595 |
| 105 | MAP4K1 | 0.56911804 |
| 106 | LMTK2 | 0.55857594 |
| 107 | MAP2K4 | 0.55595937 |
| 108 | DDR2 | 0.55457881 |
| 109 | PDK1 | 0.54758989 |
| 110 | PNCK | 0.54409052 |
| 111 | NEK2 | 0.54328012 |
| 112 | DYRK1B | 0.53992625 |
| 113 | RPS6KA5 | 0.53380323 |
| 114 | PHKG1 | 0.52675189 |
| 115 | PHKG2 | 0.52675189 |
| 116 | CLK1 | 0.52432983 |
| 117 | BUB1 | 0.52367517 |
| 118 | CDC42BPA | 0.51960742 |
| 119 | MUSK | 0.49760918 |
| 120 | MAPK12 | 0.49675075 |
| 121 | EPHB2 | 0.48711020 |
| 122 | STK38 | 0.48449332 |
| 123 | MARK2 | 0.48163591 |
| 124 | MAP3K10 | 0.47424434 |
| 125 | CAMK1D | 0.46185544 |
| 126 | DYRK1A | 0.45184518 |
| 127 | PDGFRA | 0.44888557 |
| 128 | IRAK2 | 0.44526936 |
| 129 | PRKCI | 0.43798580 |
| 130 | PTK2 | 0.43670098 |
| 131 | MAP3K13 | 0.42987604 |
| 132 | BMX | 0.42305306 |
| 133 | PRKACG | 0.42056184 |
| 134 | RPS6KA3 | 0.40987217 |
| 135 | CDK12 | 0.40687320 |
| 136 | CAMK2B | 0.40632882 |
| 137 | ARAF | 0.39997532 |
| 138 | MAPK8 | 0.39569135 |
| 139 | PRKD1 | 0.38919923 |
| 140 | CAMK2D | 0.38552525 |
| 141 | FYN | 0.38487451 |
| 142 | ERBB2 | 0.37503791 |
| 143 | RPS6KA1 | 0.36711905 |
| 144 | TYRO3 | 0.35627291 |
| 145 | MAPK4 | 0.35532181 |
| 146 | CAMK4 | 0.34815755 |
| 147 | CAMK1 | 0.34504807 |
| 148 | ABL2 | 0.33881254 |
| 149 | CHUK | 0.31820237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 4.66985158 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.43381207 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15543993 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.90002975 |
| 5 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.78457072 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.75456202 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.72335529 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24356245 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.20691132 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.20475838 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.15211421 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.09068809 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03115279 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02837238 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.97242058 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.94225959 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89377291 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87792554 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85319243 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.83853063 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.82148463 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.81092505 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.78147723 |
| 24 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.75687022 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72683655 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.72220390 |
| 27 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.64454587 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.63439915 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.62391982 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61257421 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55357501 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.53122828 |
| 33 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52317091 |
| 34 | Alcoholism_Homo sapiens_hsa05034 | 1.51822872 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.38229453 |
| 36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.38066362 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35484940 |
| 38 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.33496085 |
| 39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.30654308 |
| 40 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.29127904 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.29010952 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.20147852 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.18518640 |
| 44 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.18228731 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16361280 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15768206 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15574852 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15344902 |
| 49 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.14472744 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 1.14304543 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.13862971 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 1.13072608 |
| 53 | Malaria_Homo sapiens_hsa05144 | 1.06344052 |
| 54 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06096622 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04667753 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02808120 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 1.01973685 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.01966922 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 1.01781941 |
| 60 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01680950 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00863624 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.00043250 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.99557741 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98073127 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97630664 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96516773 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96128231 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96070614 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95394230 |
| 70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94619609 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92694547 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.90577055 |
| 73 | Peroxisome_Homo sapiens_hsa04146 | 0.88819111 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87452348 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87205276 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86262319 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85022151 |
| 78 | Melanogenesis_Homo sapiens_hsa04916 | 0.84517191 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84245286 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83849238 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.82740612 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82396997 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80989037 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79489485 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78477433 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77162869 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76119625 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75717576 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75642399 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.74737569 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.74590333 |
| 92 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74529782 |
| 93 | * Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74226333 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74197039 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74139144 |
| 96 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72415020 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.72142392 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71129618 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70653319 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70008289 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69410484 |
| 102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68805399 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68722664 |
| 104 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68080721 |
| 105 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.67881473 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65167250 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.64970604 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64769780 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63748875 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.62907613 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62761103 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.62681608 |
| 113 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62648725 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60796304 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60221197 |
| 116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59929871 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59396209 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58939287 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58852649 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.58647897 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58637761 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56859085 |
| 123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56481168 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56103581 |
| 125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.55159288 |
| 126 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52379138 |
| 127 | Long-term depression_Homo sapiens_hsa04730 | 0.51691612 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51632113 |
| 129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50859433 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50348153 |
| 131 | Gap junction_Homo sapiens_hsa04540 | 0.50167627 |
| 132 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49745863 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.49220789 |
| 134 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49152374 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49122124 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.48904140 |
| 137 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48683684 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.48324913 |
| 139 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48105620 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47793306 |
| 141 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45982206 |
| 142 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45759262 |
| 143 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45211405 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.44848140 |
| 145 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43801969 |
| 146 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43207843 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42932863 |
| 148 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42663872 |
| 149 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41665124 |
| 150 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41592318 |
| 151 | Hepatitis B_Homo sapiens_hsa05161 | 0.40791425 |
| 152 | Salmonella infection_Homo sapiens_hsa05132 | 0.40514477 |
| 153 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40468622 |
| 154 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40159857 |
| 155 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39834314 |
| 156 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39116232 |
| 157 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39006246 |
| 158 | Renin secretion_Homo sapiens_hsa04924 | 0.38973138 |
| 159 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38580965 |
| 160 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.37892155 |
| 161 | Histidine metabolism_Homo sapiens_hsa00340 | 0.37792010 |
| 162 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37279853 |
| 163 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37086752 |
| 164 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35418687 |

